resources

Akums Drugs & Pharmaceuticals Ltd.

NSE: AKUMS

BSE: 544222

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

678.40+3.4 (+0.50%)

23 Oct, 12:00 AM

Overview Analysis Statements Technicals Forecast Peers Resources

News

Annual Reports and Financial Documents

Akums Drugs & Pharmaceuticals Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.

	2024	2025	2026
Annual Reports	—	FY 2025	FY 2026
Quarterly Results	Jun Sept Dec	Dec	Mar Jun
Conference Calls	4Sept 15Nov	11Feb 2Jun 18Aug 17Nov	19Feb 21May 13Aug
Presentations	24Aug 9Nov	7Feb 26May 8Aug 13Nov	13Feb 14May 8Aug

Corporate Announcements and Regulatory Filings

Akums Drugs & Pharmaceuticals Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.

General15 Oct 2026
Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Demand Notice
Demand Notice - National Pharmaceuticals Pricing Authority
Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 20189 Oct 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018
Closure of Trading Window25 Sept 2026
Closure of Trading Window
Closure of Trading Window
Analyst / Investor Meet23 Sept 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of the Institutional Investors Meets
Analyst / Investor Meet16 Sept 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Investors/Analysts Meet
General3 Sept 2026
ESG Rating
Intimation of ESG Rating
Analyst / Investor Meet25 Aug 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of the Investors/Analysts Meet
General24 Aug 2026
Update On Schedule Of The Investors/Analysts Meet To Be Held On August 25, 2026
Akums Drugs and Pharmaceuticals Limited has informed the exchange about an update on schedule of the Investors/ Analysts Meet to be held on August 25, 2026
Analyst / Investor Meet13 Aug 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of the Investors/Analysts Meet
Analyst / Investor Meet10 Aug 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of the Investors/Analysts Meet to be held on August 14, 2026
Analyst / Investor Meet10 Aug 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Link of audio recording of Investors/Analysts Conference Call
General10 Aug 2026
Newspaper Publication
Newspaper Publication
General10 Aug 2026
Monitoring Agency Report
Monitoring Agency Report for the quarter ended June 30, 2026
General8 Aug 2026
Press Release
Press Release
Outcome of Board Meeting8 Aug 2026
Board Meeting Outcome for Un-Audited Financial Results For The Quarter Ended 30Th June, 2026
Un-audited Financial Results for the Quarter ended 30th June, 2026
Analyst / Investor Meet5 Aug 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of schedule of the Analysts/ Investor Conference Call (Group Meet) for un-audited financial results of Q1 FY27
Analyst / Investor Meet5 Aug 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of schedule of the Analysts/ Investor Conference Call (Group Meet) for un-audited financial results of Q1 FY27
Board Meeting5 Aug 2026
Board Meeting Intimation for Un-Audited (Standalone & Consolidated) Financial Results For The Quarter Ended On 30Th June, 2026
Akums Drugs And Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2026 ,inter alia, to consider and approve the un-audited ....
Acquisition23 Jul 2026
Announcement under Regulation 30 (LODR)-Acquisition
Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015- Acquisition of Oriflame India''s Manufacturing Business
AGM11 Jul 2026
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Voting Results and Scrutinizer''s Report of the 22nd Annual General Meeting

Frequently Asked Questions

Where can I download the annual report of Akums Drugs & Pharmaceuticals Ltd.?

Annual reports of Akums Drugs & Pharmaceuticals Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.

Where can I find the quarterly results of Akums Drugs & Pharmaceuticals Ltd.?

Quarterly earnings results and presentations of Akums Drugs & Pharmaceuticals Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.

Does Akums Drugs & Pharmaceuticals Ltd. publish earnings call transcripts?

Earnings call transcripts of Akums Drugs & Pharmaceuticals Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.

Where can I find investor presentations of Akums Drugs & Pharmaceuticals Ltd.?

Investor presentations and annual day presentations of Akums Drugs & Pharmaceuticals Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.

What are the recent corporate announcements of Akums Drugs & Pharmaceuticals Ltd.?

Corporate announcements and regulatory filings of Akums Drugs & Pharmaceuticals Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.

How do I access the regulatory filings of Akums Drugs & Pharmaceuticals Ltd.?

Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Akums Drugs & Pharmaceuticals Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.

What is the ISIN of Akums Drugs & Pharmaceuticals Ltd.?

The ISIN (International Securities Identification Number) of Akums Drugs & Pharmaceuticals Ltd. is INE09XN01023. This is the unique identifier used across exchanges and depositories.

On which stock exchange is Akums Drugs & Pharmaceuticals Ltd. listed?

Akums Drugs & Pharmaceuticals Ltd. is listed on NSE and BSE. The NSE symbol is AKUMS and the BSE code is -.

Where can I find the shareholding pattern of Akums Drugs & Pharmaceuticals Ltd.?

The quarterly shareholding pattern of Akums Drugs & Pharmaceuticals Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.

How current is the data for Akums Drugs & Pharmaceuticals Ltd. on Sharpely?

Share price data for Akums Drugs & Pharmaceuticals Ltd. is updated as of 23 Oct 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.